“Alzheimer’s is a difficult burden to bear for both patients and their families, which is why the Alzheimer’s Association and the Ad Council have teamed up with WNYC Studios’ Snap Judgement to launch the “Listenline.” The campaign features...
“The woman’s genetic profile showed she would develop Alzheimer’s by the time she turned 50. She, like thousands of her relatives, going back generations, was born with a gene mutation that causes people to begin having memory and thinking problems in their 40s...
“I have spent my entire career interested in the mysteries of the brain: what it looks like, how it works and what happens when it doesn’t. Alzheimer’s disease has been the primary focus of my professional life, starting as a young researcher looking at brain...
“Researchers probing the mystery of Alzheimer’s disease have found a brain protein in the brain that may stop the disorder in its tracks. The protein, called TOM-1, helps regulate inflammation in the brain. “Scientists have known for a long time that...
“Tacrine, also known as its brand name Cognex, was the first drug approved by the FDA for the treatment of Alzheimer’s disease. At the time of its approval in 1993, tacrine was considered an effective therapy for mild-to-moderate Alzheimer’s. The drug was able...
“Global information analytics giant Elsevier announced last week that the United States is the world’s top producer of Alzheimer’s research. But while scientists in the US are playing an integral role in the understanding of Alzheimer’s, the content of research...
